PTHLH and prostate cancer: In fact, in the bone metastatic setting, RANKL expression is boosted by prostate cancer cells through the expression of parathyroid hormone-related protein (PTHrP), and in parallel, bone resorption is modified by the expression of matrix metalloproteinase-7 (MMP7) by osteoclasts [40,41].